Literature DB >> 3573270

The effects of red blood cell infusion on 10-km race time.

A J Brien, T L Simon.   

Abstract

The purpose of this study was to investigate the effect of infusion of 400 mL of red blood cells (RBCs) on 10-km track race time, submaximal heart rate, hematocrit, 2,3-diphosphoglycerate, and partial pressure of oxygen at 50% hemoglobin saturation. Six highly trained, male, distance runners twice donated a unit of RBCs, which was frozen for subsequent reinfusion. Eleven weeks after the second donation, they undertook a series of three competitive 10-km races on a standard 400-m track: before infusion, after 100 mL of saline solution, and after 400 mL of autologous, previously frozen deglycerolized RBCs. All subjects took all trials in this double-blind, placebo, crossover, experimental design. Running time was recorded at each 400-m split, and blood was collected prior to each trial. The data were analyzed by analysis of variance. Results following the RBC infusion showed a significantly higher hematocrit concentration, a significantly faster 10-km run, a nonsignificant decrease in submaximal heart rate (10 beats faster 10-km run, a nonsignificant decrease in submaximal heart rate (10 beats per minute), and no significant changes in either 2,3-diphosphoglycerate or partial pressure of oxygen at 50% hemoglobin saturation. Erythrocythemia induced by the infusion of 400 mL of autologous packed RBCs effectively increased performance capacity in a 10-km track race, probably due to an increase in oxygen delivery to the working muscles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3573270

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  25 in total

1.  The future of doping control in athletes. Issues related to blood sampling.

Authors:  K I Birkeland; P Hemmersbach
Journal:  Sports Med       Date:  1999-07       Impact factor: 11.136

Review 2.  Drugs for increasing oxygen and their potential use in doping: a review.

Authors:  Aurelie Gaudard; Emmanuelle Varlet-Marie; Francoise Bressolle; Michel Audran
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 3.  Blood boosting.

Authors:  S Leigh-Smith
Journal:  Br J Sports Med       Date:  2004-02       Impact factor: 13.800

Review 4.  Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.

Authors:  Ken Fitch
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

Review 5.  Performance-enhancing substances in sports: a review of the literature.

Authors:  Amit Momaya; Marc Fawal; Reed Estes
Journal:  Sports Med       Date:  2015-04       Impact factor: 11.136

6.  Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.

Authors:  J J Thomsen; R L Rentsch; P Robach; J A L Calbet; R Boushel; P Rasmussen; C Juel; C Lundby
Journal:  Eur J Appl Physiol       Date:  2007-08-01       Impact factor: 3.078

7.  Diurnal normobaric moderate hypoxia raises serum erythropoietin concentration but does not stimulate accelerated erythrocyte production.

Authors:  Spencer R McLean; Jon C Kolb; Stephen R Norris; David J Smith
Journal:  Eur J Appl Physiol       Date:  2006-01-14       Impact factor: 3.078

Review 8.  Sports haematology.

Authors:  D J Shaskey; G A Green
Journal:  Sports Med       Date:  2000-01       Impact factor: 11.136

Review 9.  Blood doping--a literature review.

Authors:  M Jones; D S Tunstall Pedoe
Journal:  Br J Sports Med       Date:  1989-06       Impact factor: 13.800

Review 10.  Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.

Authors:  Jules A A C Heuberger; Joost M Cohen Tervaert; Femke M L Schepers; Adriaan D B Vliegenthart; Joris I Rotmans; Johannes M A Daniels; Jacobus Burggraaf; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.